Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients

By Ciancio G.   Burke G.W.   Suzart K.   Mattiazzi A.   Rosen A.   Zilleruello G.   Abitbol C.   Montane B.   Miller J.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1944-1945

Elsevier

Access to resources Recommend Favorite

Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine a

By Behr T.M.   Richter K.   Fischer P.   Spes C.H.   Meiser B.   Reichart B.   Pongratz D.   Feucht H.   Theisen K.   Angermann C.E.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1920-1921

Elsevier

Access to resources Recommend Favorite

High incidence of severe infections in heart transplant recipients receiving tacrolimus

By Peraira J.R.   Segovia J.   Arroyo R.   Ortiz P.   Fuertes B.   Monivas V.   Burgos R.   Alonso-Pulpon L.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1999-2000

Elsevier

Access to resources Recommend Favorite

Tacrolimus pharmacokinetics in heart transplant

By Sgrosso J.L.   Araujo G.L.   Vazquez M.C.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 142-143

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes

By Sundberg A.K.   Smith L.D.   Somerville K.T.   Cox R.   Sherbotie J.R.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1951-1952

Elsevier

Access to resources Recommend Favorite